Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era.

ABSTRACT:

SUBMITTER: Qualls D 

PROVIDER: S-EPMC10407681 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature